Role of linezolid therapeutic drug monitoring in the treatment of MRSA tracheo-pulmonary infection in a 10-month-old infant

Elio Castagnola, Giuliana Cangemi, Roberto Bandettini, Michele Torre, Lucio Zannini, Pietro Tuo, Andrea Moscatelli

Research output: Contribution to journalArticlepeer-review

Abstract

The paper reports on the use of therapeutic drug monitoring for linezolid in the decision-making process to continue or not its administration in an infant. Linezolid is effective against methicillin-resistant Staphylococcus aureus but is off-label in pediatrics. The use of therapeutic drug monitoring, as in our case, allows an informed decision on administration of the drug (in this case on withdrawal) increasing patients safety.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalJournal of Chemotherapy
DOIs
Publication statusAccepted/In press - Jul 24 2016

Keywords

  • Linezolid
  • Paediatrics
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Role of linezolid therapeutic drug monitoring in the treatment of MRSA tracheo-pulmonary infection in a 10-month-old infant'. Together they form a unique fingerprint.

Cite this